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Robert H. Geelkerken, MD, PhD, Jeroen J. Kolkman, MD, PhD, and Ad B, Huisman, MD, PhD, Enschede,
The Netherlands
The article byMichael Peck et al describes a large single-center
experience of splanchnic artery stenting and as such it is valuable
for all physicians taking care of patients who are presenting with
this pathology.
There are four relevant take-home messages from the present
report: (1) at least 10% of patients with chronic abdominal symp-
toms and splanchnic artery stenoses does not perceive initial ben-
efit from revascularization; (2) the 1- and 3-year primary patency
rates were 79% and 64%, respectively; (3) the 1- and 3-year
symptom-free recurrence rates were 81% and 61%, respectively;
and (4) due to the improved symptom-free recurrence rate of
two-vessel revascularization as opposed to one-vessel, two-vessel
should be pursued.
Although there is an important caveat that should be kept in
mind when interpreting the results of this series, the difference
between primary patency and symptom-free recurrence indicates
that some patients have had (recurrent) symptoms without (recur-
rent) stenosis. This underscores how difficult the diagnosis of
chronic splanchnic ischemia sometimes is and how essential it is for
a valid functional test for assessing splanchnic blood flow. Gastric
exercise tonometry, validated over the past decade,1 is such a test
and has the ability to differentiate between asymptomatic splanch-positive function test is a prerequisite to prove the causal relation-
ship between chronic abdominal symptoms and splanchnic artery
stenoses.
Apart from the obvious downsides of a retrospective series, the
validity of this study clearly suffers from lack of a uniform indica-
tion and follow-up protocol. As a consequence, it is not clear
whether all patients with recurrent symptoms were identified; at
least 25% of the patients could have developed asymptomatic
restenosis. The observation that only 27% of the patients with
appropriate radiologic follow-up were free of restenosis is a further
indication that many recurrent stenoses may have been missed.
Although we agree with the authors that an endovascular-first
approach to chronic splanchnic ischemia can be defended, we
submit that these conclusions must be interpreted with caution as
they are based on retrospective series without a complete and
validated diagnostic process and without complete and objective
follow-up. At this time, however, this is the best available evidence.
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